Compass Therapeutics, Inc.

Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 14 Oct 2026
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com
Investing.com UK · 02 Oct 2026
Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares
Investing.com · 02 Oct 2026
At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares.
Stock Titan · 02 Oct 2026
Compass Therapeutics CAO Neil Lerner Purchases 20,000 Shares in Open Market Transaction
Kalkine Media · 02 Oct 2026
Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares
Investing.com · 25 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.